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Summary
Dense maps of short-tandem-repeat polymorphisms (STRPs) have allowed genome-wide searches
for genes involved in a great variety of diseases with genetic influences, including common complex
diseases. Generally for this purpose, marker sets with a 10 cM spacing are genotyped in hundreds
of individuals. We have performed power simulations to estimate the maximum possible inter-
marker distance that still allows for sufficient power. In this paper we further report on
modifications of previously published protocols, resulting in a powerful screening set containing
229 STRPs with an average spacing of 18–3 cM. A complete genome scan using our protocol
requires only 80 multiplex PCR reactions which are all carried out using one set of conditions and
which do not contain overlapping marker allele sizes. The multiplex PCR reactions are grouped by
sets of chromosomes, which enables on-line statistical analysis of a set of chromosomes, as sets of
chromosomes are being genotyped. A genome scan following this modified protocol can be
performed using a maximum amount of 2–5 lg of genomic DNA per individual, isolated from
either blood or from mouth swabs.
1. Introduction
The localization of genes in genome-wide searches is
performed by the use of saturated maps of short-
tandem-repeat polymorphisms (STRPs) or micro-
satellite loci. Recent applications of STRP maps are
genome scans for genes involved in common multi-
factorial diseases such as type II diabetes (Mahtani et
al., 1996; Ghosh et al., 1998, 1999) and osteoarthritis
(Chapman et al., 1999) or for quantitative trait loci
(QTL) determining quantitative variables associated
with disease risk (Xu et al., 1999).
Genome scans thus far comprise genotypings of on
average 400 microsatellite marker loci at 10 cM
spacing in hundreds of individuals and are extremely
time-consuming. To increase the efficiency, a balanced
choice of markers can be made based on the maximum
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possible spacing to limit the number of genotypings at
a minimum risk of type II errors. To minimize
genotyping errors, tri- and tetranucleotide repeat
polymorphisms can more accurately be scored than
CA-repeat polymorphisms, because of greatly reduced
strand slippage during amplification and concomitant
simplification of banding patterns. Additionally, CA-
repeat loci have a mutation rate 1–5–2 times higher
than tetranucleotide repeat loci (Chakraborty et al.,
1997). Multiplex PCR reactions, amplifying several
STRPs simultaneously, should be developed in which
markers in the same reaction do not overlap.
We have modified existing protocols of Human
Screening Set 8 (Yuan et al., 1997), developed by the
Marshfield Medical Research Foundation, for genome
scanning in which minimal amounts of genomic DNA,
including DNA collected by the non-invasive mouth
swab procedure (Meulenbelt et al., 1995), are required.
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2. Materials and methods
(i) Power simulation
Power simulations were based on 500 unselected sib
pairs and a trait heritability of 75%. Simulations were
carried out for markers with a heterozygosity of 75%.
The QTL effect accounted for 25% of the phenotypic
variance and the QTL was always located between
two loci. Data were analyzed using a maximum-
likelihood variance components approach modelling
the full 2‹2 sibship covariance structure (Fulker &
Cherny, 1996), with pi-hats estimated from IBD
distributions obtained from running Mapmaker}SIBS
(Kruglyak & Lander, 1995).
(ii) Marker set
The Human Screening Set 8 (Yuan et al., 1997) was
used as a basis for composing the alternative screening
set. The primer sequences and the inter-marker
distances are available at the Marshfield Medical
Research Foundation web site (http:}}research.
marshfieldclinic.org}genetics).
(iii) DNA isolation
Genomic DNA was isolated from whole blood and
from mouth swabs using a chloroform:isoamylalcohol
(24:1) extraction method (see below). Mouth swabs
were taken from subjects according to our previously
published method (Meulenbelt et al., 1995), but since
the chloroform:isoamylalcohol (24:1) extraction
method appeared to be as successful as the phenol}
chloroform extraction we used the former. The mouth
swabs were collected from participants by post. Mouth
swabs were taken and stored by the participants in
STE buffer (100 mM NaCl, 10 mM EDTA, 10 mM
Tris) including 0–1 mg}ml proteinase K and 0–5%
SDS. When the swabs arrived by post in the TNO
laboratories, the proteinase K concentration was
increased to 0–2 mg}ml and the swabs were incubated
at 65 °C for 2 h. After centrifugation of the samples as
described (Meulenbelt et al., 1995), 0–2 volume of 8 M
KAc was added to the lysate and mixed well but
gently. The mixture was kept on ice for 15 min. One
volume of chloroform:isoamylalcohol (24:1) was
added and placed in a top-over for half an hour.
Subsequently, samples were centrifuged and isopro-
panol was added to the supernatant for precipitation
of genomic DNA. DNA of 1911 individuals was
obtained using this mouth swab procedure and the
average yield per cotton bud was 2–0 lg (SD 1–4)
genomic DNA. Depending on the subject taking the
mouth swab, the DNA yield is quite variable. For
DNA extraction from whole blood lysis was per-
formed as usual, followed by the same extraction steps
as for mouth swabs.
(iv) PCR conditions
The PCR was performed in 96 wells V-microtitre
plates (Biozyme) in a total volume of 10 ll. The
reaction mix contained 10 ng genomic DNA template,
isolated from either whole blood or mouth swabs;
PCR buffer as supplied with the enzyme by the
manufacturer (Amersham Pharmacia Biotech) ; 0–073
lM of each primer, of which the forward primer was
labelled with Cy5 (Amersham Pharmacia Biotech) ;
200 lM each of dATP, dTTP, dGTP, dCTP
(Amersham Pharmacia Biotech) ; and 0–2 units recom-
binant Taq DNA polymerase (Amersham Pharmacia
Biotech). To make the multiplex PCR reaction
successful, it was only necessary in some cases to
adapt the final primer concentration. The PCR
reactions were performed in PTC-100 machines (MJ
Research). The program consisted of an initial
denaturation for 1 min at 94 °C, followed by 27 cycles
of 30 s denaturing at 94 °C, 75 s annealing at 55 °C
and 15 s extension at 72 °C, which were concluded
with a final extension of 6 min at 72 °C.
(v) Electrophoresis
The electrophoresis and fragment separation were
performed using short gel systems of the automated
laser fluorescent DNA sequence analyzer ALFexpress
(Amersham Pharmacia Biotech). When Sequagel-6
(National Diagnostics) was used, the gel could be
loaded twice with PCR products and when High
Resolution ReproGel (Amersham Pharmacia Biotech,
which polymerizes during 10 min of exposure to UV
light, was used, the gel could be loaded at least three
times in subsequent order, still resulting in sharp peak
patterns.
(vi) Genotyping
The allele analysis was performed using Fragment
Analyser software (Amersham Pharmacia Biotech).
The genotypes of the parents of eight CEPH families
(102, 884, 1331, 1332, 1347, 1362, 1413 and 1416)
were used for composing the allelic standards. Each
genotype was reviewed manually by two individuals
to confirm the accuracy of allele calling.
3. Results
Simulations showed that genome scans with a spacing
of 20 cM have enough power to detect QTL effects,
which account for 25% of the phenotypic variance of
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Table 1. Composition of the screening sets of
chromosomes
Set of chromosomes Multiplex reaction numbers
1, 8, 11, 19 1–23, 42, 43, 67
6, 7, 16 6, 9, 10, 13, 14, 18, 20, 24–31
2, 15, 17 7, 8, 10, 13, 18, 32–43
5, 9, 14 12, 16, 19, 40, 41, 44–54, 78
3, 4, 10 11, 15, 29, 40, 51, 55–64, 78
12, 13, 18 6, 12, 52–54, 62, 65–72
20, 21, 22, X, Y 15, 17, 21, 52, 54, 62, 72–80
a trait with a heritability of 75%, in a population of
500 sib pairs. The 25 cM Human Screening Set 8a
appears to have too little power in searches for such
QTLs and the 10 cM Human Screening Set 8 (Yuan
et al., 1997) seems too elaborate. Therefore, we com-
posed an alternative set of 229 markers based on the
Human Screening Set 8 with an average spacing of
18–3 cM (SD 3–9). The average heterozygosity of these
markers is 0–77 (SD 0–06) and 86–5% are tri- and
tetranucleotide repeat polymorphisms.
The Marshfield Medical Research Foundation
described multiplex PCR combinations for their
10 cM spaced screening set (http:}}research.
marshfieldclinic.org}genetics). We redesigned the
composition of markers in each multiplex PCR and
the corresponding conditions. The resulting 80 multi-
plex PCR reactions (Appendix) are grouped by
markers randomized over sets of 3 to 5 chromosomes
(Table 1) to enable statistical analysis of the search
data before finishing the whole genome scan at large.
In addition, a margin of at least 15 base pairs between
allele sizes of different markers in a multiplex was
chosen to avoid overlap.
A protocol was developed in which only 10 ng
genomic DNA per multiplex PCR reaction is used.
Hence, a complete genome scan requires at most 2–5
lg of genomic DNA. Our protocol is successful using
DNA isolated from whole blood as well as from
mouth swabs. After evaluation of 90000 genotypes,
which were performed in 16 months using two
ALFexpress (Amersham Pharmacia Biotech) systems,
the average genotypic error rate was less than 1% and
the average missing data rate was 8% using this
protocol.
4. Discussion
We performed power simulations and adapted existing
protocols in order to limit the number of genotypings
in a genome scan and still retain sufficient power in
statistical analysis. This resulted in a set of 229
markers, measured in 80 multiplex PCR reactions,
with an average inter-marker distance of 18–3 cM. The
high percentage of tri- and tetranucleotide repeat
markers reduces the percentage of genotypic errors.
The markers in each multiplex PCR reaction, which
all require the same PCR conditions, allow 15 base
pairs spacing of alleles to avoid overlap. The geno-
typings were performed using an ALFexpress system
(Amersham Pharmacia Biotech), but these multiplex
PCR reactions can easily be used in other genotyping
equipment.
Multiplex PCR reactions were composed from
marker combinations grouped by sets of several
chromosomes. Statistical analysis can therefore be
performed per set of chromosomes, while other
sets are being genotyped. Using our protocol,
fine-mapping of positive chromosome regions could
be started at an earlier stage.
Due to the adapted PCR conditions, smaller than
usual amounts of DNA are required. For a whole-
genome scan using our protocol, at most 2–5 lg
of genomic DNA is required, whereas for a
10 cM spaced genome scan of the Marshfield
Medical Research Foundation (http:}}research.
marshfieldclinic.org}genetics), a 6-fold increment of
genomic DNA is required.
Finally, our genotyping procedure is successful on
genomic DNA isolated from blood as well as from
mouth swabs collected by post. The use of DNA
isolated from mouth swabs is especially suitable for
studies involved in geographically scattered subjects
and for studies in which it is not feasible to obtain
blood from participants. In conclusion, we have
increased the efficiency of genome scanning and
developed a protocol to facilitate scanning on small
quantities of genomic DNA.
Appendix. List of loci in multiplex reactions
Reaction
number
Chromosome Marker
name
Locus
name
1 8 GAAT1A4
11 GATA28D01 D11S2000
1 GATA72H07 D1S2134
2 8 GATA26E03 D8S1132
11 GATA90D07 D11S2371
1 GATA87F04 D1S2141
3 8 143XD8 D8S264
19 GATA29B01 D19S589
11 GATA6B09 D11S1392
1 GATA4A09 D1S547
4 1 ATA29D04 D1S1631
8 GATA14E09 D8S2324
5 1 GGAA3A07 D1S1612
8 UT721 D8S373
11 GATA26H10 D2S2739
6 8 COS140D4 D8S136
11 GATA23F06 D19S1999
18 ACT1A01 D18S843
6 ATA50C05 D6S2434
7 8 GATA25C10 D8S1130
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1 GATA50F11 D1S1609
17 AFM044XG3 D17S784
8 8 GGAA20C10 D8S1477
11 ATA27C09 D11S2359
1 ATA29C07 D1S3462
2 GATA71D01 D2S1776
9 6 GATA31 D6S474
1 GGAA22G10 D1S1677
19 GATA66B04 D19S714
10 17 GATA185H04 D17S2196
7 GATA189C06 D7S3070
1 GATA48B01 D1S1660
11 10 ATA31G11 D10S1412
1 GATA12A07 D1S534
4 GATA28F03 D4S3248
3 GGAT2G03 D3S2406
12 13 GATA51B02 D13S796
1 ATA4E02 D1S1589
5 AFM164X68 D5S408
13 2 GGAA20G04 D2S1399
8 AFM073Y67 D8S256
1 ATA20F08 D1S1622
6 GATA64D02 D6S1053
14 6 GGAT3H10 D6S1017
7 MFD265 D7S559
1 GATA165C03 D1S3728
15 X GATA31F01 DXS6789
1 GATA29A05 D1S3669
4 ATA26B08 D4S2394
16 1 AFM280WE5 D1S468
5 GATA145D09 D5S2848
17 19 GATA44F10 D19S591
1 GATA6A05 D1S551
X GATA69C12 DXS6810
18 2 GATA65C03 D2S1391
16 AFM031XA5 D16S402
8 GGAA8G07 D8S1113
19 8 GATA7G07 D8S1179
9 AFM308VB1 D9S282
20 11 AFM157XH6 D11S912
16 GATA22F09 D16S3253
6 GATA68H04 D6S1056
7 GATA118G10 D7S3046
21 11 GATA23E06 D11S1998
X AFM150F10 DXS1047
22 11 GGAA17G05 D11S1984
19 GATA21G05 D19S1034
23 11 GATA48E02 D11S1981
24 16 AFM350VD1 D16S516
7 GATA3F01 D7S820
6 GATA81B01 D6S1277
25 6 ATA22G07 D6S1027
7 GATA24F03 D7S3056
16 GATA71F09 D16S2621
26 6 GATA165G02 D6S2436
7 GATA41G07 D7S1802
16 GATA71H05 D16S769
27 16 ATA41E04 D16S2616
7 GATA31A10 D7S2846
28 16 GATA42E11 D16S764
7 GATA32C12 D7S1824
6 GATA32B03 D6S1009
29 3 GATA22G12 D3S2387
7 GATA5D08 D7S821
30 7 AFM217YC5 D7S513
6 GATA163B10 D6S2439
31 7 GGAA6D03 D7S3061
6 F13A1 SE30
16 GATA67G11 D16S2620
32 15 ACTC ACTC
17 ATA43A10 D17S2193
2 GATA116B01 D2S2952
33 2 AFM112YD4 D2S125
17 AFM217YD10 D17S928
15 GATA27A03 D15S642
34 2 GATA30E06 D2S2944
15 GATA63A03 D15S659
17 GATA64B04 D17S1303
35 17 ATC6A06 D17S2180
2 GATA86E02 D2S1788
15 GATA88H02 D15S822
36 2 GATA11H10 D2S1360
15 AFM323YD9 D15S211
17 GTAT1A05 D17S1308
37 17 GATA28D11 D17S1301
2 GATA165C07 D2S2976
15 ATA24A08 D15S652
38 17 GATA49C09 D17S1290
2 GATA4D07 D2S1334
15 GATA22F01 D15S657
39 2 GATA4E11 D2S410
15 GATA151F03 D15S1507
17 GAAT2C03 D17S1298
40 10 GGAA5D10 D10S1213
2 GATA69E12 D2S1394
3 GATA22F11 D3S2427
9 GATA62F03 D9S2169
41 2 GATA178G09 D2S2968
5 ATA20G07 D5S2488
42 19 MFD238 D19S254
2 GATA23D03 D2S1363
43 19 MFD232 D19S246
2 GATA88G05 D2S1790
44 5 GATA21D04 D5S1457
9 GATA27A11 D9S925
14 ATA19H08 D14S592
45 5 GATA52A12 D5S1501
14 GATA136B01 D14S1426
9 GATA87E02 D9S1121
46 9 ATA18A07 D9S910
14 GATA4B04 D14S306
47 5 GATA67D03 D5S2500
9 AFM73YB11 D9S158
14 GATA74E02 D14S742
48 14 MFD190 D14S53
5 MFD154 D5S211
9 GATA21F05 D9S922
49 14 GGAA21G11 D14S617
9 GATA7D12 D9S301
5 GATA3E10 D5S817
50 14 GATA43H01 D14S608
9 ATA59H06 D9S2157
5 GATA68A03 D5S2501
51 3 GATA27C08 D3S2432
5 GATA6E05 D5S820
9 GATA48D07 D9S930
52 20 GATA81E09 D20S604
5 GATA3A04 D5S807
12 PAH PAH
53 12 GATA26D02 D12S1052
5 GATA89G08 D5S1725
13 GATA43H03 D13S793
54 20 GATA51D03 D20S482
5 GATA11A11 D5S1456
18 GATA6D09 D18S851
55 3 AFM254VE1 D3S1311
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4 GATA107 D4S1625
10 GATA115E01 D10S2470
56 4 GATA22G05 D4S2366
3 GATA68D03 D3S2459
10 GGAA23C05 D10S1248
57 4 GATA72G09 D4S2632
3 ATA34G06 D3S4523
10 GATA48G07 D10S1237
58 4 GATA90B10 D4S2639
10 GATA70E11 D10S1423
3 GATA3H01 D3S1763
59 4 GATA10G07 D4S3243
3 GATA6F06 D3S1766
10 GATA87G01 D10S1435
60 4 GATA2F11 D4S1647
10 ATA24F10 D10S1225
3 GATA4A10 D3S1764
61 10 ATA5A04 D10S1208
4 AFM165XC11 D4S408
3 GATA6G12 D3S2398
62 4 GATA5B02 D4S1652
X GATA175D03 DXS9902
12 GATA11H08 D12S391
63 4 GATA8A05 D4S1629
10 AFM189ZB4 D10S212
3 AFM234TF4 D3S1304
64 X GATA124E07 DXS9896
4 GGAA19H07 D4S2431
65 12 ATA25F09 D12S2070
18 ATA7D07 D18S1357
13 ATA26D07 D13S779
66 12 ATA27A06 D12S1042
18 GATA88A12 D18S976
13 GGAA29H03 D13S1493
67 12 GGAT2G06 D12S398
19 MFD235 D19S245
13 GATA29A09 D13S788
68 18 ATA1H06 D18S844
69 12 GATA63D12 D12S1064
70 18 GATA64H04 D18S877
12 GATA4H03 D12S372
13 GATA23C03 D13S787
71 13 AFM309VA9 D13S285
12 GATA13D05 D12S392
18 ATA82B02
72 X GATA165B12
13 GATA7G10 D13S317
12 GATA32F05 D12S2078
18 GATA178F11
73 20 AFM046XF6 D20S171
22 GCT10C10 D22S1685
Y GATA30F10 DYS389
X GATA72E05 DXS7132
74 22 GGAT3C10 D22S445
X GGAT3F08 DXS9900
21 GATA70B08 D21S1446
75 21 GGAA3C07 D21S1437
22 GATA6F05 D22S685
X GATA182E04 DXS9908
76 21 GATA129D11 D21S2052
18 GATA11A06 D18S542
20 GATA42A03 D20S478
77 21 GATA188F04 D21S2055
XY SDF1 DXYS154
20 GATA45B10 D20S480
78 22 AFM217XF4 D22S420
3 AFM036YB8 D3S1259
5 GATA2H09 D5S816
79 20 AFM077XD3 D20S103
21 GATA11C12 D21S1432
Y GGAAT1B07
80 X GATA172D05
10 GATA87G01 D10S1432
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